Multicenter Clinical Observation of Guilonghulou Coating Agent in Prevention and Treatment of Thrombosis of Autologous Arteriovenous Fistula in Hemodialysis Patients

the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Patients who meet the diagnostic criteria of uremia stage of chronic renal failure and have been treated with hemodialysis for 3 months or more; (2) Patients who have undergone autologous arteriovenous fistula surgery and met the maturity criteria of arteriovenous fistula in the first edition of Chinese consensus on vascular access for hemodialysis in 2014, and who have begun to puncture arteriovenous fistula for hemodialysis; (3) Blood flow of internal fistula can meet the criteria. The hemodialysis blood flow of patients was more than 250ml/min, the age of patients was between 18 and 80 years old, and the gender was not limited. (4) Informed consent to participate in the study and sign the informed consent.

•(1) Mental disorders, cognitive impairment, unable to cooperate with the study smoothly; (2) Coagulation dysfunction, with a significant bleeding tendency; (3) Autoimmune deficiency; (4) Allergic constitution or allergic to a variety of drugs; and (5) Poor compliance.

发起方

the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine